Am I Eligible?

You can take part in the RAUORA study if you:

  • Smoke cigarettes every day
  • Both Māori and non-Māori (as whānau of Māori) can join the study. Whānau of Māori means people who aren’t themselves Māori by whakapapa, but live in a Māori whānau, e.g. in a household by marriage.
  • Want to quit smoking in the next two weeks
  • Are aged 18 years or over
  • Have daily access to a mobile phone that can text and/or email and/or have access to the internet via a computer or smartphone
  • Living in the Lakes District Health Board region (eg. Taupo, Turangi, Rotorua and everywhere in between), Eastern Bay of Plenty (eg. Edgecombe, Kawerau, Whakatane, Kawerau, Opotiki and everywhere in between), or around Tokoroa
  • Have tried, but failed, to quit smoking two or more times using nicotine replacement treatments, such as nicotine patches or gum
  • Have tried previously to quit smoking using Zyban (bupropion) or Norpress (nortriptyline)
  • Are able and prepared to provide verbal consent to take part

You cannot take part in this study if you:

  • Are pregnant or breastfeeding
  • Are enrolled in another smoking cessation programme (e.g.  Quitline) or another smoking cessation study
  • Have used Champix or Tabex in the past 12 months
  • Are currently using another method to stop smoking (including e-cigarettes)
  • Have moderate or severe renal impairment (kidney disease or kidney/renal failure)
  • Are being treated for active or latent TB (Tuberculosis)
  • Have been treated for a heart attack, stroke, or severe angina within the last two weeks
  • Have uncontrolled high blood pressure (> 150 mmHg systolic, > 100 mmHg diastolic)
  • Have a history of seizures

Sorry, but only one person per household can take part.

Recruiting Now

If you think you’d like to take part in our trial click here to read our participant information sheet.  This sheet will tell you more about the trial, who can and can’t be involved, and what it involves.

If you’ve read the participant information sheet and are keen to express interest in joining the trial, please contact us